Stevens First Principles Investment Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-200	Closed	-$12K	–	248
2015 Q2	$12K	Sell	200 -600	-75%	-$34.2K	0.01%	192
2015 Q1	$46K	Buy	+800	New	+$53.6K	0.03%	135

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stevens First Principles Investment Advisors's KITE Position: Q3 2015 in Review

Stevens First Principles Investment Advisors sold out of Kite Pharma, Inc. (KITE) in Q3 2015, closing a stake of 200 shares — an estimated $12K sold.

Stevens First Principles Investment Advisors first reported a position in KITE in Q1 2015 and held it in 2 quarters. The position peaked at $46K in Q1 2015. 155 funds tracked by Wall St. Rank hold KITE as of Q3 2015.

Stevens First Principles Investment Advisors reported no remaining Kite Pharma, Inc. position as of Q3 2015 after selling out during the quarter.
Stevens First Principles Investment Advisors sold 200 Kite Pharma, Inc. shares in Q3 2015, an estimated $12K.
Stevens First Principles Investment Advisors first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 2 quarters.
Stevens First Principles Investment Advisors's Kite Pharma, Inc. position peaked at $46K in Q1 2015.
155 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2015.

Based on Stevens First Principles Investment Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.